Multiple Dose Study of RO7795068 and its effect on Gastric Emptying, and on PK of Oral Contraceptives
BP45910
Phase 1 other active
Quick answer
Multiple Dose Study of RO7795068 and its effect on Gastric Emptying, and on PK of Oral Contraceptives for Healthy Overweight or Obese is a Phase 1 program (other) at Hoffmann-La Roche with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Hoffmann-La Roche
- Indication
- Healthy Overweight or Obese
- Phase
- Phase 1
- Modality
- other
- Status
- active